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ABSTRACT
Objectives To determine the extent and nature of 
changes in utilisation of healthcare services during 
COVID-19 pandemic.
Design Systematic review.
Eligibility Eligible studies compared utilisation of services 
during COVID-19 pandemic to at least one comparable 
period in prior years. Services included visits, admissions, 
diagnostics and therapeutics. Studies were excluded if 
from single centres or studied only patients with COVID-19.
Data sources PubMed, Embase, Cochrane COVID-19 
Study Register and preprints were searched, without 
language restrictions, until 10 August, using detailed 
searches with key concepts including COVID-19, health 
services and impact.
Data analysis Risk of bias was assessed by adapting the 
Risk of Bias in Non- randomised Studies of Interventions 
tool, and a Cochrane Effective Practice and Organization 
of Care tool. Results were analysed using descriptive 
statistics, graphical figures and narrative synthesis.
Outcome measures Primary outcome was change in 
service utilisation between prepandemic and pandemic 
periods. Secondary outcome was the change in 
proportions of users of healthcare services with milder or 
more severe illness (eg, triage scores).
Results 3097 unique references were identified, and 
81 studies across 20 countries included, reporting on 
>11 million services prepandemic and 6.9 million during 
pandemic. For the primary outcome, there were 143 
estimates of changes, with a median 37% reduction in 
services overall (IQR −51% to −20%), comprising median 
reductions for visits of 42% (−53% to −32%), admissions 
28% (−40% to −17%), diagnostics 31% (−53% to −24%) 
and for therapeutics 30% (−57% to −19%). Among 35 
studies reporting secondary outcomes, there were 60 
estimates, with 27 (45%) reporting larger reductions in 
utilisation among people with a milder spectrum of illness, 
and 33 (55%) reporting no difference.
Conclusions Healthcare utilisation decreased by about a 
third during the pandemic, with considerable variation, and 
with greater reductions among people with less severe 
illness. While addressing unmet need remains a priority, 
studies of health impacts of reductions may help health 
systems reduce unnecessary care in the postpandemic 
recovery.
PROSPERO registration number CRD42020203729.
INTRODUCTION
As the COVID-19 pandemic continues, many 
studies have reported major changes in utili-
sation of healthcare services because of such 
measures as lockdowns and stay- at- home 
orders.1–3 These changes include large reduc-
tions in services, particularly in places hit 
hard by the pandemic, but also some selective 
increases, such as for telemedicine.4 Many 
people have missed out on much needed 
care, such as vaccination or life- extending 
interventions for cancer.2 5 6 A WHO survey 
found disruption to healthcare services 
greatest among lower income countries,7 and 
there are estimates that reduction of essen-
tial maternal and child health interventions 
may cause more than a million additional 
child deaths.8 Concurrently, the pandemic 
may also have resulted in some people being 
spared unnecessary or inappropriate care 
which has the potential to cause harm.9 10 The 
problem of too much medicine is well docu-
mented,11–17 and multiple global campaigns 
are addressing this challenge, such as 
Choosing Wisely, which is active in more than 
20 countries.18 As some nations are forced to 
Strengths and limitations of this study
 ► The review is the first broad synthesis of global 
studies of pandemic- related changes in utilisation 
across all categories of healthcare services.
 ► The review provides novel findings informing design 
of future studies of pandemic- related changes in 
utilisation and its impacts.
 ► Limitations include the possibility of publication bias 
and the potential of our eligibility criteria to exclude 
important data sources such as studies in single 
centres and unpublished data sets from health 
systems.
 ► Heterogeneous designs and settings precluding 
meta- analysis.
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do more with less in the postpandemic period, learning 
from this ‘natural experiment’ in reduced care may help 
health systems identify and address unnecessary care, and 
move towards greater sustainability.9 10
Investigating the impact of changes in healthcare util-
isation on health outcomes and costs presents major 
methodological challenges. First, there are many reasons 
why people have missed care, including fear of becoming 
infected while visiting a care facility, inability to access care 
due to lockdown policies and suspension and cancella-
tion of services such as elective surgery. Second, disentan-
gling populations who have missed necessary care from 
those who have avoided unnecessary care requires sensi-
tive and nuanced analysis, with adjustment for multiple 
potentially confounding variables. For instance, simply 
showing no adverse outcomes in the short term from 
missing an episode of care does not prove it was unneces-
sary. Notwithstanding these challenges, quantifying and 
characterising the unprecedented recent changes in util-
isation, and their impact on health outcomes and costs, 
may help health systems optimise postpandemic use of 
resources.
To this end, we conducted what is, to our knowl-
edge, the first systematic review of studies reporting on 
pandemic- related changes in overall healthcare utilisa-
tion. In undertaking this review, we also sought to inform 
and optimise the design of future investigations of both 
the ongoing changes in utilisation, and the impacts of 
this natural experiment with less care on health outcomes 
and costs.
METHODS
As per a detailed protocol registered on PROSPERO19 
and uploaded to the Open Science Framework20 (online 
supplemental file 1) we found, appraised and synthesised 
studies that compared healthcare utilisation during the 
COVID-19 pandemic with a corresponding prepandemic 
period. Our abstract and full review follow the Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
(PRISMA) statements21 22 (online supplemental file 2).
Eligibility criteria and search strategy
Inclusion and exclusion criteria
We included studies which compared utilisation of health-
care services over a period of time during the pandemic, 
as defined by their authors (the intervention) with a 
corresponding period in the year/s before the pandemic 
(the comparator). Healthcare service utilisation included 
but was not limited to visits or presentations, admis-
sions or hospitalisations, diagnostic services and thera-
peutic or preventive interventions. Letters or preprints 
were included if providing enough data for extraction. 
We excluded surveys of practitioners, studies reporting 
only on utilisation by patients diagnosed with COVID-
19, studies reporting utilisation data for less than 1 week, 
from a single centre only, or for non- medical allied health 
services, and modelling studies that predicted impacts on 
utilisation.
Outcome measures
The primary outcome was the change in utilisation of a 
healthcare service—such as a visit to a hospital or receipt 
of diagnostic imaging—between the prepandemic and 
pandemic periods, expressed as a change in absolute 
numbers and/or percentage change. The secondary 
outcome was change in the proportions of people using 
the service, across different levels of disease severity, as 
reported by authors of the primary study, using, for 
example, a triage score.
Data sources, searches and screening
We searched PubMed, Embase, the Cochrane COVID-19 
Study Register and preprint servers via Europe PMC from 
inception until 10 August 2020, with search strings that 
included the following broad concepts: COVID-19, health 
services, admissions and impact (online supplemental file 
3). No restrictions by language were imposed. Following 
screening of articles for inclusion, we conducted a back-
ward (cited) and forward (citing) citation analysis in 
Scopus/Web of Science on all included studies, and 
additional articles were screened for inclusion. We also 
consulted experts for other public reports.
Pairs of review authors (RM, SS, ZAM, AMS, JC, EK, 
EJT, LA) independently screened the titles and abstracts 
against the inclusion criteria, and repeated the process 
following full- text retrieval. Any screening disagreements 
were resolved by discussion, or reference to a third author 
(RM or LA). A list of studies in single centres, excluded at 
screening stage, was recorded and is available on request 
from authors.
Data collection and analysis
Data extraction
Pairs of authors (RM, SS, ZAM, AMS, EJT, LA) inde-
pendently extracted data from included studies and 
resolved discrepancies, with referral, as necessary, to a 
third author (LA, RM). We developed, piloted and used 
a data extraction form in Microsoft Excel for study char-
acteristics and outcome data. We extracted data on study 
location, design, setting (eg, hospital), pandemic period 
and comparator, and primary and secondary outcomes.
Pairs of review authors (RM, SS, ZAM, AMS, LA, EJT) 
independently assessed the risk of bias for each included 
study using a risk of bias tool adapted from the Risk of 
Bias in Non- randomized Studies of Interventions tool23 24 
as per guidance provided by Cochrane for assessing risk 
of bias in uncontrolled before- after studies including 
interrupted time series,23 and a tool developed by the 
Cochrane Effective Practice and Organization of Care 
group.25 All disagreements were resolved by discussion 
or referral to a third author (RM, LA, SS). The domains 
assessed included bias related to: confounding ((A) the 
possibility that extraneous events occurring around the 
time of the pandemic may have influenced the outcome, 
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(B) how well the study accounted for preintervention 
trends in utilisation); selection of participants; outcome 
measurement; and selective reporting of results (online 
supplemental file 4). Each potential source of bias was 
graded as low, high or unclear, with the exception of 
grading for the preintervention trends, which was graded 
as low, moderate or high.
Data synthesis and analysis
As anticipated in the protocol, the considerable clin-
ical and statistical heterogeneity in settings, outcome 
measures and methods precluded a formal quantitative 
meta- analysis. Hence, we summarised the results using 
descriptive statistics (percentage change expressed as 
median and IQR), graphical figures and a narrative 
synthesis. In line with the ‘Synthesis without meta- analysis 
(SWiM) in systematic reviews: reporting guideline’,26 we 
summarised findings for the primary outcome grouped 
by four service types: visits or presentations; admissions or 
hospitalisations; diagnostic or imaging investigations; and 
therapeutic or preventive interventions.
For the secondary outcome, given the wide variation 
in how severity was reported in the primary studies, we 
developed and report three categories which relied on 
the indicators of disease severity employed by primary 
study authors: a larger or smaller reduction among those 
with milder forms of illness, compared with people with 
more severe forms of illness; and no difference. An 
example of a secondary outcome for a study of emergency 
department (ED) visits would be the triage scores, used to 
assess severity of those attending. Two authors (RM, LA) 
independently assigned a category for each secondary 
outcome, informed where possible by statistics provided 
in primary studies, with oversight and resolution of any 
discrepancies from within the clinical authorship team 
(IS, EL, MiJ).
As per details in the protocol, we planned to conduct a 
limited meta- analysis and sensitivity analysis in situations 
where there was a sufficient number of clinically and 
statistically homogeneous studies. Also, as per protocol, 
we restricted our analysis to data in the primary studies, 
rather than correlating findings with external informa-
tion, such as stages of lockdown.
Patient and public involvement
The most senior officer from a state peak consumer 
health organisation is a coauthor on this review and was 
involved in the study before the protocol was finalised. 
The consumer representative provided feedback on the 
protocol and draft manuscripts, was consulted during the 
process of the review, was involved with interpretation of 
results and will advise on methods for dissemination of 
study results to the public.
Changes from protocol
Several minor changes comprised: during data extraction 
we could not confidently assess whether each used service 
was not provided or just deferred; finalisation of the 
adapted tool for risk of bias resulted in five domains, 
not six (two domains related to outcome measurement 
were combined), with one domain assessed as low, 
moderate, high, rather than unclear, low and high, with 
each grade supported by a comment; and given the very 
large number of included studies, we included data from 
studies reporting only a percentage change in service util-




We identified 4817 records through electronic database 
searching, 323 more through forward- backward citation 
analysis and 1 from other sources, for a total of 3097 
unique records. After screening titles and abstracts, we 
excluded 2929 records, and selected 179 records for full- 
text screening, of which 98 were excluded with reasons 
recorded. This left 81 studies which were included in the 
review (figure 1).
Characteristics of included studies
The 81 included studies collectively report on more than 
6.9 million services in the pandemic and over 11 million 
in the comparator prepandemic period. Studies reported 
across multiple locations: 3 were multinational; 20 origi-
nated from the USA; 15 from Italy; 8 from France; 6 from 
Germany; 5 from the UK; 3 from Spain; 2 from each of 
Taiwan, Hong Kong, Greece, Denmark, Qatar, Australia; 
and 1 from each of Argentina, China, Canada, Brazil, 
Belgium, Chile, Monaco, Turkey and Portugal. Four 
studies were from low- income or middle- income coun-
tries. The healthcare setting was: hospitals only (41; 51%); 
both ED and hospitals (12; 15%); ED only (15; 19%); 
and primary care and/or community (9; 11%). More 
than one- third of studies reported on healthcare services 
related to cardiovascular diseases (n=33; 41%); 14 (17%) 
to emergency services; 12 (15%) to general services such 
as immunisation and primary care; and 22 (27%) on 
services related to different conditions including ortho-
paedic and trauma services, gastroenterology and mental 
health. Of the included studies, 14 (17%) were national 
studies and 9 (11%) used time- trend data (table 1; online 
supplemental file 5).
Risk of bias assessment
For the majority of studies there was insufficient infor-
mation on which to judge the possibility that extraneous 
events occurring between prepandemic and pandemic 
periods may have influenced healthcare utilisation, or 
to assess the risk of bias arising from differences between 
those eligible to use healthcare services in the prepan-
demic and pandemic periods (76/81; 94%). Sixty- nine 
per cent (56/81) of studies were considered to be at high 
risk of bias due to insufficient data for characterising 
prepandemic utilisation. In contrast, 3 (4%) studies were 
judged to be at low risk of bias on this domain due to 
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adequate data and analysis to permit characterisation of 
prepandemic trends in utilisation. Sixty- three per cent 
(51/81) of studies were judged to be at high or unclear 
risk of bias from using different methods used to assess 
utilisation in the prepandemic and pandemic periods, or 
lacking information on which to judge this domain. Most 
studies (n=74; 91%) were judged to be at low risk of bias 
in selective reporting of results (figure 2).
Main findings
The 81 studies reported 143 estimates of changes in 
healthcare utilisation between pandemic and prepan-
demic periods, of which 136 (95.1%) were a reduction. 
The percentage change ranged from a 49% increase to 
an 87% decrease with a median 37.2% reduction (IQR 
−50.5% to −19.8%). For the 64 estimates about changes 
in cardiovascular service utilisation, from 33 studies, 
the median reduction was 29.3% (−41.3% to −17%). 
For the 13 estimates from the nine studies using time- 
trend data, the median reduction was 37.3% (−45% to 
−25.2%). For all studies, the weekly median percentage 
changes starting from mid- February until late May 2020 
are plotted graphically in figure 3, showing greatest 
reductions through March and April (full data in online 
supplemental file 5).
We categorised the 143 estimates of change into four 
groups according to the type of healthcare service: 41 esti-
mates for healthcare visits; 43 estimates for admissions; 
12 estimates for diagnostics (eg, imaging, pathology, 
screening investigations); and 47 estimates for therapeu-
tics (eg, surgery, vaccinations). All medians are reported 
in table 2, with results of individual studies reported in 
online supplemental file 5.
Changes in visits
The percentage change for healthcare visits or presen-
tations ranged from a 49% increase to an 86% decrease, 
with a median 42.3% reduction (−52.8% to −31.5%). 
Major reductions in visits to EDs were seen in multiple 
studies, such as a large national US study from the 
Centers for Disease Control and Prevention reporting 
a 42% reduction during April, rising to a 26% reduc-
tion at the end of May, compared with 2019.1 That study 
found the largest absolute reduction involved people 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) flow diagram.
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presenting with abdominal pain, with over 66 000 fewer 
ED visits per week for this complaint during April. In 
terms of age group, the largest reduction (−72%) was 
seen for children 10 years and under.1 A meta- analysis 
of a subgroup of six studies of ED visits that reported 
adequate data for meta- analysis (effect estimates and 
95% CIs) was attempted, but demonstrated considerable 
heterogeneity (I2>95%).
Figure 2 Summary of risk of bias assessments.
Table 1 Summary characteristics of included studies (n=81)
Characteristics of included studies n (%)
Scope
  National 14 (17)
  Multicentre 67 (83)
Disease categories
  Cardiovascular 33 (41)
  Emergency services (adult and paediatric) 14 (17)
  General (including vaccination and hospice) 12 (15)
  Digestive 5 (6)
  Orthopaedic and trauma 5 (6)
  Others (eg, mental health, urology, neurology) 12 (15)
Setting
  Hospitals (or inpatient care) 41 (51)
  Emergency 15 (19)
  Emergency and hospital 12 (15)
  Community and/or outpatient 9 (11)
  Hospital and outpatient 4 (5)
Study design*
  Time trend
  Time trend—multiple prior year 5 (6)
  Time trend—single prior year 4 (5)
  Same period (before–after)
  Same period—multiple prior year 16 (20)
  Same period—single prior year 56 (69)
Country
  Multinational 3 (4)
  Americas 24 (30)
  Europe 45 (56)
  Asia and Australia 9 (11)
*This refers to the type of data used in included studies rather than the type of analysis.
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Changes in admissions
The percentage change in the number of admissions 
ranged from a 20% increase to an 87% decrease, with 
a median 28.4% reduction (−40.4% to −17.4%). For 
example, a large study of the weekly admission rates for 
acute coronary syndrome in England showed a substan-
tial reduction by the end of March (−40%) which partly 
rebounded by the last week of May 2020 (−16%).27
Changes in diagnostics
The percentage reduction ranged from 10% to 85%, 
with a median 31.4% reduction (−52.5% to −23.8%); 
no study reported any increase in the use of diagnostic 
and imaging procedures. The magnitude of reductions 
in diagnostic tests and imaging followed a trend over 
time similar to those observed in the previous catego-
ries, but with a far smaller number of estimates (see 
online supplemental files 4 and 5). For example, a study 
of imaging case volumes within the largest healthcare 
system in New York State found a 28% reduction in 
imaging volumes for March to mid- April 2020 across all 
locations and imaging modalities,28 while a separate US 
study found volumes recovering through late April, but 
still 36% lower in the third week of May, compared with 
2019.29
Changes in therapeutics
The percentage change in therapeutic and preventive 
care ranged from a 27% increase to an 80% decrease, 
with a median 29.6% reduction (−56.8% to −19.2%). 
For example, a large study of routine childhood vaccina-
tion in England found fewer children receiving the first 
measles- mumps- rubella dose, with a reduction of 24% in 
the final week of March, which rose to a 27% increase in 
the third week of April, compared with the same period 
in 2019.5
Secondary outcome
Thirty- eight of the included studies reported a total of 
60 secondary outcomes relating to potential changes in 
healthcare utilisation according to the disease severity of 
the service user. Despite the considerable heterogeneity 
in settings and services, for almost half of these outcomes 
(27 of 60; 45%), we observed a pattern of larger reduc-
tions in utilisation among those with milder or less severe 
illness compared with those with more severe disease. 
For 33 of 60 outcomes (55%) there was no difference 
(figure 4). No studies reported a smaller reduction 
among those with milder forms of illness.
A national Italian study of urgent endoscopy reported 
a 40% reduction in utilisation overall, with bigger reduc-
tions in the proportion of patients with a negative finding 
Figure 3 Pandemic- related changes in healthcare utilisation.
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on upper endoscopy between prepandemic and pandemic 
periods.3 A study of three psychiatric emergency services 
in Paris found a 55% overall reduction in presentations in 
the first 4 weeks of lockdown, with greater reductions for 
consultations for anxiety and stress, and smaller reduc-
tions for consultations for psychotic disorders.30 Authors 
speculated that ‘some people may find new strengths 
and coping strategies during disasters’ and ‘the current 
results may arise from an elevation in resilience’. Most 
strikingly, multiple studies reporting reduced acute coro-
nary syndrome presentations found these reductions 
were much greater for the less severe non- ST- segment 
elevation myocardial infarction (NSTEMI) events 
compared with ST- segment elevation myocardial infarc-
tions (STEMIs).27 31 An example is a large English study 
reporting reductions in admissions of 42% for NSTEMI 
events versus 23% for STEMI.27 In contrast, other studies 
found no change in presentations according to severity, 
including a national Portuguese study reporting a 48% 
reduction in ED episodes—from an expected 570 000 to 
an observed 295 000 in March 2020—but no significant 
change in proportions of different triage categories.32
DISCUSSION
This review of 81 studies involving over 17.9 million 
services provided across 20 countries found consistent 
evidence of major reductions in the utilisation of health-
care services during the pandemic period up to May 
2020, compared with previous years, despite some studies 
reporting increases. Although a meta- analysis was not 
possible, we found a median reduction of 37% of services 
Table 2 Median changes in utilisation across categories of healthcare services
Healthcare service
Number of estimates 
(number of studies)





Total 143 (81) 19 808 921
(P: 6 948 834; C: 11 102 936)
−37.2 −50.5% to −19.8%
Healthcare services categories*
  Visits 41 (33) 14 090 495
(P: 4 631 899; C: 7 723 639)
−42.3 −52.8% to −31.5%
  Admissions 43 (32) 1 690 021
(P: 749 942; C: 939 737)
−28.4 −40.4% to −17.4%
  Diagnostics 12 (7) 1 692 388
(P: 640 885; C: 1 051 503)
−31.4 −52.5% to −23.8%
  Therapeutics 47 (28) 2 336 017
(P: 926 108; C: 1 388 057)
−29.6 −56.8% to −19.2%
Disease categories
  CVD 64 (33) 2 586 270
(P: 1 166 610; C: 1 400 041)
−29.3 −41.3% to −17.0%
  Emergency services 17 (14) 10 572 517
(P: 3 252 399; C: 5 585 161)
−44.0 −48.0% to −31.5%
Study design and data
  Studies using time- trend data 13 (9) 6 263 331
(P 1 974 605; C: 3 425 412)
−37.3 −45.0% to −25.2%
*Each study could have included services across multiple categories. In order to calculate the total volume of healthcare services, we used 
numbers as reported in the primary studies, whenever available. If not explicitly reported, we estimated these numbers using data plotted in 
the figures reported in the primary studies, when available. For studies that have not reported these absolute numbers anywhere—but only 
reported a percentage change—their services have not been included in these totals. In addition, there will be some discrepancy between 
the total numbers, and the sum of pandemic and prepandemic periods, because in some cases, a study may have included a total number of 
services, but without breaking it down into any absolute numbers for the pandemic or prepandemic period.
C, comparator prepandemic period; CVD, cardiovascular disease; P, pandemic period.
Figure 4 Differential reductions in utilisation relating to 
severity.
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overall, which was highest for visits (42%) and slightly 
lower for admissions (28%), diagnostics (31%) and ther-
apeutics (30%). Many studies also found larger reduc-
tions in utilisation among populations with milder or less 
severe illness. Few studies were assessed as having a low 
risk of bias, with lowest risk of bias for studies using time- 
trend data to establish trends in the years leading up to 
2020. For the nine studies using time trends, the median 
reduction in utilisation was 37%.
Our review has several strengths. First, we synthesised 
the most recent data reported in primary studies up to 
the end of May 2020, which corresponds to the peak of 
the pandemic in many countries, and provides a baseline 
for longer term data on ongoing changes in utilisation 
and the cumulative deficit of care. Second, the review 
constitutes the first broad synthesis of global studies of 
pandemic- related changes in utilisation across all catego-
ries of healthcare services. Third, the review adhered to 
rigorous Cochrane,24 PRISMA21 22 and SWiM26 standards. 
Study limitations include the inability to undertake a 
meta- analysis because of considerable heterogeneity, the 
possibility of publication bias, the potential of our eligi-
bility criteria to exclude important data sources such as 
studies in single centres and unpublished data sets from 
health systems, subjectivity in our assessments of the 
secondary outcomes and the use of an adapted but unval-
idated risk of bias tool.
The massive global reduction in healthcare utilisa-
tion summarised in this review makes a compelling case 
for prioritising efforts that address the unmet needs of 
those with non- COVID-19 illness. Consistent messages 
from the primary studies include calls for monitoring the 
long- term impacts of this missed care, public campaigns 
to urge people to seek medical care when they need it 
and better preparedness for reducing the extent of 
missed care in future waves of the pandemic. Evidence 
of excess population mortality, in addition to deaths from 
COVID-19, and related phenomena such as increases in 
out- of- hospital cardiac arrests and contacts with emer-
gency phone lines33 34 make these calls to action even 
more urgent. Conversely, the review’s finding that reduc-
tions often tended to be greater for milder or less severe 
forms of illness, combined with existing evidence about 
too much medicine,11–17 suggests that for some people, 
missing care may not have caused harm.
This unprecedented pandemic- induced natural 
experiment in reduced healthcare utilisation provides a 
genuine opportunity to learn more about what services 
populations and healthcare systems came to regard as 
lesser priorities, when redistribution of resources towards 
more essential services was needed to minimise mortality 
in a crisis. As others have suggested,35 36 greatly reduced 
ED attendances around the world for non- urgent 
complaints indicate an opportunity to inform and imple-
ment new strategies and models of care that maximise 
the appropriateness of visits in the future. Even at the 
heart and height of the epidemic in Northern Italy, in 
paediatric EDs doctors found reductions in the mildest 
presentations accounted for more of the decrease in 
overall presentations, suggesting that ‘most of the non- 
relevant pathologies usually seen at our EDs have been 
avoided’, thus freeing resources to ‘provide critical 
services to patients suffering from medical emergencies 
in a timely manner’.36 Our review adds weight to the view 
that the postpandemic recovery provides a rare window of 
opportunity for systematic changes in healthcare systems 
aimed at reducing low- value care, including overtreat-
ment and overdiagnosis.9 10 37
Many questions about the causes and impacts of the 
changes in healthcare utilisation documented in our 
review call for careful analysis and further research (see 
box 1). High- quality time- trend analyses are needed 
to better understand the extent and nature of ongoing 
changes in utilisation, as are long- term cohort studies for 
collecting patient- centred outcomes to assess impacts on 
health, costs and equity. Consultations with consumers 
during the pandemic highlight the need to understand 
how the pandemic may differentially impact the most 
vulnerable, and the need to prioritise those at most 
need.38 39 Rigorous qualitative research investigating 
people’s experience of avoiding or missing care, and 
professional responses to changes in process and practice, 
will also be important. We found no study which explicitly 
examined changes in utilisation of low- value healthcare 
Box 1 Future research
 ► For future studies of changes in healthcare utilisation during the 
pandemic
Aim for time- series analyses; multiple years prepandemic as 
comparator.
Aim to detect impacts on equity, such as different groups differen-
tially affected.
Need to cautiously interpret drivers and impacts of changes.
Aim to analyse local, provincial and national data sets.
Consider potential for multinational research collaborations with 
health systems.
 ► For future studies of impacts of the ‘natural experiment’ in reduced 
care
Aim for long- term cohort studies, with focus on specific conditions, 
or interventions.
Seek strong clinical, patient and public input, independence of com-
mercial interests.
Qualitative analyses with patients and public on reasons for and im-
pacts of missing care.
 ► For those interested in opportunity to address problem of too much 
medicine
Studies of pandemic- related changes in rates of overtreatment and 
overdiagnosis.
Urgent need to learn from ‘natural experiment’ before rates return 
to prior levels.
Correlate condition- specific granular analyses, with existing data on 
medical overuse.
Consider using pandemic learnings to guide trials of deimplemen-
tation strategies.
Consider potential researcher–clinician–consumer–health system 
collaborations.
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services, which warrants further research. The extent and 
effects of substitution, such as with telehealth or self- care, 
also require investigation. Experience with severe acute 
respiratory syndrome almost 20 years ago revealed signif-
icant drops in healthcare service utilisation in the most 
affected regions40 and long periods before some rates 
returned to baseline.41 Given the growing evidence about 
unnecessary care since then, it may be more beneficial for 
populations and their health systems if utilisation rates 
of some services do not return to prepandemic levels. 
Addressing genuine unmet need and winding back the 
harm and waste of unnecessary care are not conflicting 
interests, but rather two sides of a coherent strategy to 
efficiently improve human health.
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